| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ZUO | Class A Common Stock | Sale | -$2.34M | -236K | -54.03% | $9.90 | 201K | Nov 6, 2024 | By JDH Life Sciences, Inc. | F1, F2, F3 |
| holding | ZUO | Class A Common Stock | 43.6K | Nov 6, 2024 | Direct | F4 | |||||
| holding | ZUO | Class A Common Stock | 100K | Nov 6, 2024 | By Abraxus Trust | F5 |
| Id | Content |
|---|---|
| F1 | Shares were sold by the Account Manager (as defined below) without the prior knowledge of the Reporting Person. |
| F2 | Represents the weighted average sale price. The lowest price at which shares were sold was $9.90 and the highest price at which shares were sold was $9.91. The Reporting Person undertakes to provide upon request to the staff of the U.S. Securities and Exchange Commission, Zuora or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | Reporting Person is the president and sole beneficial owner of JDH Life Sciences, Inc., and may be deemed to share voting and dispositive power with regard to the shares held by JDH Life Sciences, Inc., with Scalar Gauge Management, LLC (the Account Manager). |
| F4 | Includes 40,567 Restricted Stock Units (RSUs) granted on April 30, 2024, upon the appointment of the Reporting Person to Zuora's Board of Directors. Each RSU represents a contingent right to receive one share of Zuora's Class A Common Stock upon settlement. The RSUs will vest and convert into shares of Zuora's Class A Common Stock as to 1/3rd of the total number of RSUs subject to the award on each of April 30, 2025, April 30, 2026, and April 30, 2027, in each case, so long as the Reporting Person continues to provide services to Zuora through such date. The vesting of the RSUs shall accelerate in full upon the consummation of a Corporate Transaction, as defined in Zuora's 2018 Equity Incentive Plan. |
| F5 | Reporting Person is the trustee and sole beneficiary of the Abraxus Trust and may be deemed to have sole voting and dispositive power with regard to the shares held by the Abraxus Trust. |